Astrocyte dysfunction and excessive activation of glutamatergic systems have been implicated in a number of neurologic disorders, including periventricular leukomalacia (PVL) and cerebral palsy (CP). However, the role of chorioamnionitis on glutamate homeostasis in the fetal and neonatal brains is not clearly understood. We have previously shown that intrauterine endotoxin administration results in intense microglial 'activation' and increased pro-inflammatory cytokines in the periventricular region (PVR) of the neonatal rabbit brain. In this study, we assessed the effect of maternal inflammation on key components of the glutamate pathway and its relationship to astrocyte and microglial activation in the fetal and neonatal New Zealand white rabbit brain. We found that intrauterine endotoxin exposure at gestational day 28 (G28) induced acute and prolonged glutamate elevation in the PVR of fetal (G29, 1 day post-injury) and postnatal day 1 (PND1, 3 days post-injury) brains along with prominent morphological changes in the astrocytes (soma hypertrophy and retracted processes) in the white matter tracts. There was a significant increase in glutaminase and N-Methyl-D-Aspartate receptor (NMDAR) NR2 subunit expression along with decreased glial L-glutamate transporter 1 (GLT-1) in the PVR at G29, that would promote acute dysregulation of glutamate homeostasis. This was accompanied with significantly decreased TGF-β1 at PND1 in CP kits indicating ongoing neuroinflammation. We also show for the first time that glutamate carboxypeptidase II (GCPII) was significantly increased in the activated microglia at the periventricular white matter area in both G29 and PND1 CP kits. This was confirmed by in vitro studies demonstrating that LPS activated primary microglia markedly upregulate GCPII enzymatic activity. These results suggest that maternal intrauterine endotoxin exposure results in early onset and long-lasting dysregulation of glutamate homeostasis, which may be mediated by impaired astrocyte function and GCPII upregulation in activated microglia.
Maternal inflammation leads to impaired glutamate homeostasis and up-regulation of glutamate carboxypeptidase II in activated microglia in the fetal/newborn rabbit brain Astrocyte dysfunction and excessive activation of glutamatergic systems have been implicated in a number of neurologic disorders, including periventricular leukomalacia (PVL) and cerebral palsy (CP). However, the role of chorioamnionitis on glutamate homeostasis in the fetal and neonatal brains is not clearly understood. We have previously shown that intrauterine endotoxin administration results in intense microglial 'activation' and increased pro-inflammatory cytokines in the periventricular region (PVR) of the neonatal rabbit brain. In this study, we assessed the effect of maternal inflammation on key components of the glutamate pathway and its relationship to astrocyte and microglial activation in the fetal and neonatal New Zealand white rabbit brain. We found that intrauterine endotoxin exposure at gestational day 28 (G28) induced acute and prolonged glutamate elevation in the PVR of fetal (G29, 1 day post-injury) and postnatal day 1 (PND1, 3 days post-injury) brains along with prominent morphological changes in the astrocytes (soma hypertrophy and retracted processes) in the white matter tracts. There was a significant increase in glutaminase and N-Methyl-D-Aspartate receptor (NMDAR) NR2 subunit expression along with decreased glial L-glutamate transporter 1 (GLT-1) in the PVR at G29, that would promote acute dysregulation of glutamate homeostasis. This was accompanied with significantly decreased TGF-β1 at PND1 in CP kits indicating ongoing neuroinflammation. We also show for the first time that glutamate carboxypeptidase II (GCPII) was significantly increased in the activated microglia at the periventricular white matter area in both G29 and PND1 CP kits. This was confirmed by in vitro studies demonstrating that LPS activated primary microglia markedly upregulate GCPII enzymatic activity. These results suggest that maternal intrauterine endotoxin exposure results in early onset and long-lasting dysregulation of glutamate homeostasis, which may be mediated by impaired astrocyte function and GCPII upregulation in activated microglia.
Introduction
Neuroinflammation and glutamate excitotoxicity are common pathophysiologic mechanisms that are involved in perinatal/neonatal brain injury, including cerebral palsy (CP) (Vexler and Ferriero, 2001; Vannucci and Hagberg, 2004; Folkerth, 2005; Johnston, 2005; Johnston and Hoon, 2006; Leonardo and Pennypacker, 2009) . Glutamate is the major excitatory neurotransmitter in the mammalian central nervous system and plays important roles in a variety of physiological and pathological functions (Choi, 1988) . Glutamate is mainly produced from glutamine by glutaminase localized in neurons (Martinez-Hernandez et al., 1977; Erecinska and Silver, 1990; Westergaard et al., 1995) , astrocytes (Cardona et al., 2014) and activated microglia/macrophages (Huang et al., 2011; Thomas et al., 2014) . Glutamate can also be produced by the hydrolysis of Nacetylaspartylglutamate (NAAG), an abundant peptide neurotransmitter in the mammalian brain, into N-acetylaspartate (NAA) and glutamate by glutamate carboxypeptidase II (GCPII) that has been shown in several studies to be primarily localized to the astrocyte cell membrane in the central nervous system (CNS) (Robinson et al., 1987; Sacha et al., 2007) (Fig. 1A) and satellite cells and Schwann cells in the peripheral nervous system (Carozzi et al., 2008) .
Glial cells, such as astrocytes and microglia, play important roles in both normal brain function and in injury (Vernadakis, 1996; Vesce et al., 1999; Grady et al., 2003; Kou and VandeVord, 2014) . We have previously demonstrated that intrauterine infection with LPS induced Neurobiology of Disease 94 (2016) 116-128 
